Research Article
Impact of Body Mass Index on Short-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention in Newfoundland and Labrador, Canada
Table 3
Admitting clinical, angiographic, and procedural data for patients undergoing PCI according to BMI category.
| | | Total | NW | OW | OB | valu |
| | Number of patients | 6473 | | | | |
| | Cardiovascular history | | | | | | | Prior PCI | 6462 | 226 (21.1) | 543 (20.9) | 627 (22.5) | | | Prior CABG | 6462 | 129 (12.0) | 298 (11.5) | 289 (10.4) | | | Prior HF | 6462 | 52 (4.9) | 83 (3.2) | 106 (3.8) | | | Prior MI | 6462 | 212 (19.8) | 527 (20.3) | 581 (20.8) | | | CVD | 6450 | 89 (8.3) | 160 (6.2) | 174 (6.3) | |
| | Same sitting angioplasty | 6473 | 864 (80.5) | 2138 (82.0) | 2321 (83.1) | |
| | IABP/cardiogenic shock | 6461 | 7 (0.7) | 16 (0.6) | 31 (1.1) | |
| | Priority | 6466 | | | Low risk | 1861 | 220 (20.5) | 783 (30.0) | 858 (30.7) | | | Emergency | 397 | 72 (6.7) | 170 (6.5) | 155 (5.6) | | Urgent | 4208 | 780 (72.7) | 1654 (63.4) | 1774 (63.5) |
| | PE | 6216 | 8 (0.8) | 13 (0.5) | 15 (0.6) | |
| | Thromboembolic history | 6218 | 5 (0.5) | 12 (0.5) | 10 (0.4) | |
| | DVT | 6219 | 16 (1.6) | 32 (1.3) | 32 (1.2) | |
| | Stable angina | 1748 | 202 (18.9) | 731 (28.1) | 815 (29.3) | |
| | ACS | 4341 | | | | | | STEMI | 1227 | 251 (31.7) | 501 (29.1) | 475 (26.0) | | | Non-STEMI | 1939 | 349 (44.1) | 787 (45.6) | 803 (44.0) | | Unstable angina | 1174 | 191 (24.1) | 436 (25.3) | 547 (30.0) | | Thrombolytics contraindicated | 4143 | 11 (1.5) | 27 (1.6) | 24 (1.4) | | | Failed thrombolysis | 4274 | 26 (3.4) | 77 (4.5) | 59 (3.3) | |
| | Access site | | | | | | | Radial/brachial | 1172 | 193 (18.0) | 468 (17.9) | 511 (18.3) | | | Femoral | 5301 | 880 (82.0) | 2140 (82.1) | 2282 (81.7) |
| | Sheath size | | | | | | | Sheath size 5 Fr | 924 | 160 (14.9) | 393 (15.1) | 371 (13.3) | | | Sheath size 6 Fr | 5432 | 893 (83.2) | 2171 (83.3) | 2368 (84.9) | | Sheath size 7/8 Fr | 114 | 20 (1.9) | 43 (1.6) | 51 (1.8) |
| | Closure device | 6470 | 484 (45.1) | 1359 (52.1) | 1506 (54.0) | |
| | GP IIb/IIIa inhibitors | 6471 | 134 (12.5) | 338 (13.0) | 351 (12.6) | |
|
|
Values are presented as (%).
values for chi-squared tests.
ACS = acute coronary syndrome; BMI: body mass index; CABG: coronary artery bypass grafting; CVD: cerebrovascular disease; DVT= deep vein thrombosis; HF: heart failure; IABP: intra-aortic balloon pump; MI: myocardial infarction; NW: normal weight; OB: obese; OW: overweight; PCI: percutaneous coronary intervention; PE: pulmonary embolism; PVD: peripheral vascular disease; STEMI: ST elevation myocardial infarction.
|
